BioArtic AB & Novartis Sign Agreement Stockholm, Sweden, August 26, 2025 – BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) today announced that the company has entered into an option, collaboration and license agreement with Novartis Pharma AG (